Myocardial Infarction and AGT p.Thr174Met Polymorphism: A Meta-Analysis of 7657 Subjects

14Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background. It has been suggested that the angiotensinogen (AGT) gene rs4762 (p.Thr174Met) polymorphism might be associated with myocardial infarction (MI) risk, but the study results are still debatable. Objective and Methods. In order to explore the relationship between AGT p.Thr174Met polymorphism and MI risk, the current meta-analysis involving 7657 subjects from 11 individual studies was conducted. Results. A significant association between AGT p.Thr174Met polymorphism and MI was found under recessive (OR: 2.26, 95% CI: 1.35-3.77, P=0.002), dominant (OR: 1.131, 95% CI: 1.016-1.260, P=0.024), codominant (OR: 2.198, 95% CI: 1.334-3.621, P=0.002), and additive (OR: 1.363, 95% CI: 1.132-1.641, P=0.001) genetic models. In the Asian subgroup, significantly increased MI risk was found under all genetic models (P<0.05). No significant association between AGT p.Thr174Met polymorphism and MI was found under all genetic models in the Caucasian subgroup (P>0.05). Conclusions. AGT p.Thr174Met variant might increase MI risk, especially within the Asian population. The Met174 allele of AGT p.Thr174Met might confer the risk for MI.

Cite

CITATION STYLE

APA

Li, Y. Y., Wang, H., Wang, H., & Zhang, Y. Y. (2021). Myocardial Infarction and AGT p.Thr174Met Polymorphism: A Meta-Analysis of 7657 Subjects. Cardiovascular Therapeutics, 2021. https://doi.org/10.1155/2021/6667934

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free